Bevacizumab, an Anti-Vascular Endothelial Growth Factor Antibody, Inhibits Osteoarthritis
Arthritis Research and Therapy - United Kingdom
doi 10.1186/s13075-014-0427-y
Full Text
Open PDFAbstract
Available in full text
Date
September 18, 2014
Authors
Publisher
Springer Science and Business Media LLC